ImmuCell Corporation: capex
| Value | {"amount": 181097, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2024-01-01 – 2024-06-30 |
| Status | current |
| Entity | ImmuCell Corporation |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:07:43.661981+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/275dd617-8346-4d0d-a8b5-9c777bd4d285
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-24-068245Retrieved: 2026-08-19T08:07:43.661981+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000811641/capex/2024-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/275dd617-8346-4d0d-a8b5-9c777bd4d285
History
- no predecessors — first report